HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned ...

(RTTNews) - China Pharma Holdings, Inc. (CPHI) said its subsidiary Hainan Helpson Medical & Biotechnology Co. has received the Drug Supplementary Application Approval Notice for its candesartan ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed medical records of 50 adolescents treated at Texas Children’s Hospital Headache Clinic.

The angiotensin receptor blocker (ARB) candesartan is associated with superior neurocognitive outcomes compared with lisinopril in older adults with hypertension and mild cognitive impairment, a new ...